A Bruton tyrosine kinase inhibitor utilized to take care of mantle mobile lymphoma, Continual lymphocytic leukemia, and little lymphocytic lymphoma.A facet impact is generally considered to be an unwanted secondary effect which happens Besides the desired therapeutic impact of the drug or medication. Negative effects may perhaps fluctuate for every